Continuing Medical Education Programs
All programs are available free to the public.
Continuing Medical Education Programs
All programs are available free to the public.
Resources
For a complete list of continuing education programs, click here.
For programs in your area, visit your region website for a list of events.
To access patient education programs, click here.
Navigating the Frontier of Hematologic Malignancy Therapies
Live satellite symposium preceding the 64th American Society of Hematology (ASH) 2022 Annual Meeting
December 9, 2022
Elevating Equity in Caring for Patients with Hematologic Malignancies
Live hybrid symposium preceding the 64th American Society of Hematology (ASH) 2022 Annual Meeting
December 9, 2022
Participate and earn CME credit:
Supporting Our Colleagues: Easing the Burden of Referrals for CAR-T in Aggressive B-cell Lymphomas
This CE activity is intended for hematologic oncology clinicians who provide CAR-T therapy for individuals with aggressive B-cell lymphomas.
Identifying and Managing Complications of Acute Myeloid Leukemia in the Emergency Department
This CE activity is intended for physicians, physician assistants, nurse practitioners and nurses involved in the care of patients in the Emergency Department.
Updates in Treating Pediatric Leukemia
This CE activity is intended for oncologists, pediatric hematologist-oncologists, nurses, and oncology social workers involved in the care of patients with hematologic malignancies.
Opening the CAR(T) Door to Get Your Patients to Therapy
Part 4 of 4 in a series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes
Avoiding Roadblocks in Coordinating CAR-T Therapy for B-cell Lymphoma: Practical Tips for Community Oncology Clinicians
Part 3 of 4 in a series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes
The Road to Cures Through Immunotherapy and Precision Medicine
This activity provides learners with an overview of the latest advancements in biology and treatments for acute myeloid leukemia, aggressive lymphoma, and myeloma. The development and practical applications for CAR T-cell therapy in blood cancers is presented. A review of data from The Leukemia & Lymphoma Society patient registry on SARS-CoV-2 vaccination and antibody response in patients with blood cancer provides a glimpse of unmet needs in this vulnerable patient population.
What You MUST Know As More Lymphoma Patients Are On The Road To CAR-T
Part 2 of 4 in a series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes
It's Time To Understand CAR-T Therapy For B-Cell Lymphoma: Earlier Indications Coming To A Community Near You
Part 1 of 4 in a series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes
AML Strategies: Decision-Making at Each Point in Care
This series of four modules will provide members of the multidisciplinary cancer care team with the latest information to improve their knowledge and confidence in the diagnosis and treatment of AML through interactive online activities.
Treating Adolescents and Young Adults with Blood Cancer
For physicians, advance practice providers, and nurses involved in the care of adolescents and young adults with hematologic malignancies.